Swiss Pharma Company Announces $23 Billion U.S. Investment
Days After Trump Pledged ‘Major Tariff’ on Drug Imports
Pharmaceutical company Novartis announced plans to build seven facilities in the United States and expand others in a $23 billion investment over five years on the heels of President Donald Trump’s announcement of forthcoming tariffs on imported drugs.
